期刊
TRANSPLANTATION PROCEEDINGS
卷 49, 期 7, 页码 1656-1658出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.transproceed.2017.03.078
关键词
-
资金
- Natural Science Fund of Fujian Province [2016J01583]
- China Postdoctoral Fund [2016M590597]
Objective. To investigate the thromboembolism induced by blood-mediated inflammatory reactions against infused cells during the clinical application of stem cells. Methods. Two patients with renal transplantation and chronic kidney disease, respectively, experienced thromboembolism after umbilical cord mesenchymal stem cell (UCMSC) infusion. The clinical manifestations and the laboratory test results were collected and analyzed. Results. The patients received stem cell infusion through the peripheral veins and presented with a swollen and painful forearm postinfusion. Doppler ultrasound showed venous clots at the proximal end of the puncture site. Urokinase and warfarin were used for thrombolytic therapy. The swelling and pain were relieved and cured. Conclusion. Safety concerns are still a primary hurdle for stem cell therapy, and thromboembolism as a critical complication should be prevented appropriately.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据